期刊文献+

肠道菌群与糖尿病 被引量:6

Gut microbiota and diabetes
下载PDF
导出
摘要 近年来,肠道菌群与糖尿病的关系成为研究热点。随着对肠道菌群认识的深入,肠道菌群作为环境因素在调节免疫及代谢性疾病发生中的作用逐渐被大家认识。目前国内外已有大量研究关注肠道菌群影响肥胖和糖尿病的发病机制,也有研究发现肠道菌群能够从食物难以消化的成分中获取能量,从而影响人体的能量平衡和代谢。人们通过基因组测序的方法揭示不同类型糖尿病患者肠道菌群的组成、丰度等,并在动物体内进行验证,明确和糖尿病相关的细菌功能。肠道菌群携带的遗传信息可能是未来治疗糖尿病的新突破口。关于2型糖尿病(T2DM)及1型糖尿病(T1DM)肠道菌群的研究较多,但妊娠期糖尿病(GDM)肠道菌群的相关研究报道较少。因此,本文对不同类型糖尿病的肠道菌群特点及肠道菌群参与糖尿病发生的机制作一综述。 In recent years, the relationship between gut microbiota and diabetes has become a research hotspot. With the in-depth study of gut microbiota, the role of gut microbiota, as an environmental factor in regulating the development of immune and metabolic diseases, has been gradually recognized. At present, a large number of studies at home and abroad have focused on the pathogenesis of gut microbiota affecting obesity and diabetes. Some studies have also found that the gut microbiota can obtain energy from food components that are difficult to digest, affecting the energy balance and metabolism of human body. The genome sequencing method is used to reveal the composition and abundance of intestinal flora in different types of diabetes patients, and which can be verified in animals to clarify the bacterial functions associated with diabetes. The genetic information carried by the gut microbiota may be a new breakthrough in the future treatment of diabetes. There are many studies on gut microbiota in type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM), but there have been few reports on the gut microbiota of gestational diabetes in the past. Therefore, in this paper, the characteristics of gut microbiota in different types of diabetes and the mechanism of gut microbiota involved in the occurrence of diabetes were reviewed.
作者 张洁 徐焱成 吴玉文 ZHANG Jie;XU Yan-cheng;WU Yu-wen(Department of Endocrinology,the First Hospital of Huhhot,Huhhot 010030,China;Department of Endocrinology,Zhongnan Hospital of Wuhan University)
出处 《天津医药》 CAS 北大核心 2019年第6期667-672,共6页 Tianjin Medical Journal
基金 内蒙古自治区自然科学基金项目(2017MS0872)
关键词 肠道菌群 糖尿病 综述 gut microbiota diabetes review
  • 相关文献

参考文献4

二级参考文献48

  • 1Wang H, Chen J, Holloster K, et al. Endogenous bile acids are the nuclear receptor FXR/BAR. Mol Cell, 1999,3 : 543 - 553.
  • 2Christopher JS, Masahiro T, Masaaki M. et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell, 2000, 102 : 731 -744.
  • 3Chiang JYL, Kimmel R, Weinberger C, et al. Farnesoid X receptor responds to bile acids and represses cholesterol 7a-hydroxylase gene transcription. J Biol Chem, 2000,275 : 10918- 10924.
  • 4Bryan G, Staeey A J, Roger RP, et al. A regulatory cascade of the nuclear receptors FXR, SHP - 1, and LRH - 1 represses bile acid biosynthesis. Mol Cell, 2000, 6 : 517- 526.
  • 5Mark PA, Kast-Woelbem HR, Anisfeld AM, et al. Identification of PLTP as an LXR target gene and apoE as an FXR target reveals overlapping targets for the two nuclear receptors. J Lipid Res, 2002, 43 : 2037 -2041.
  • 6Kast HR, Nguyen CM, Sinai CJ, et al. Famesoid X activated receptors induces apolipoprotein c-II transcription: a molecule mechanism linking plasma triglycefide leveLs to bile acids. Mol Endocrinol, 2001, 15 : 1720 - 1728.
  • 7Urizar NL, Liveryman AB, Dodd's DT, et al. A natural product that lowers cholesterol as antagonist ligand for FXR. Science, 2002, 296 : 1703- 1706.
  • 8Hua Tu, Okamoto AY, Bei Sha. FXR, a Bile Acid Receptor and Biological Sensor. TCM, 2000, 10 : 30 -34.
  • 9Bjorkhem I. Mechanism of bile acid biosynthesis in mammalian liver. Elsiver Sci Pub, 1985, 231 - 277.
  • 10Pikuleva IA, Babiker R, Waterman MR, et al. Activities of recombinant human cytochrome P450c27 ( CYP27 ) which produce intermediates of alternative bile acid biosynthetic pathway. J Biol Chem, 1989, 273 : 18153 - 18160.

共引文献210

同被引文献80

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部